Alpha Purchase Co., Ltd. (7115.T)
JPY 1149.0
(1.86%)
JPY 1149.0
(1.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 51.95 Billion | 44.38 Billion | 37.94 Billion | 32.44 Billion |
| Cost of Revenue | 47.12 Billion | 40.03 Billion | 34.04 Billion | 29.03 Billion |
| Gross Profit | 4.82 Billion | 4.34 Billion | 3.9 Billion | 3.41 Billion |
| Operating Expenses | 3.64 Billion | 3.3 Billion | 3.04 Billion | 2.67 Billion |
| Selling, General and Administrative Expenses | 3.04 Billion | 2.8 Billion | 3.04 Billion | 2.67 Billion |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | -1.29 Million | 404 Thousand | -27.98 Million |
| Cost and Expenses | 50.76 Billion | 43.34 Billion | 37.08 Billion | 31.7 Billion |
| Operating Income | 1.18 Billion | 1.04 Billion | 864.42 Million | 741.34 Million |
| Interest Expense | 282 Thousand | 1.05 Million | 1.97 Million | 2.99 Million |
| Income Tax Expense | 332.33 Million | 290.23 Million | 213.91 Million | 204.69 Million |
| Earnings before Tax | 1.18 Billion | 994.34 Million | 724.79 Million | 711.23 Million |
| Net Income | 850.7 Million | 704.11 Million | 510.88 Million | 506.53 Million |
| Earnings Per Share Basic | 89.51 | 84.91 | 61.96 | 54.62 |
| Earnings Per Share Diluted | 87.01 | 83.49 | 61.96 | 54.62 |
| Weighted Average Shares Outstanding | 9.5 Million | 8.29 Million | 8.24 Million | 9.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.77 Million | 8.43 Million | 8.24 Million | 9.27 Million |
| Gross Margin | 0.09 | 0.10 | 0.10 | 0.11 |
| EBIT Margin | 0.03 | 0.03 | 0.04 | 0.03 |
| Profit Margin | 0.02 | 0.02 | 0.01 | 0.02 |
| EBITDA | 1.79 Billion | 1.52 Billion | 1.23 Billion | 1.07 Billion |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 13.22 Billion | 13.56 Billion | 14.61 Billion | 51.95 Billion | 12.4 Billion | 12.67 Billion |
| Cost of Revenue | 12 Billion | 12.35 Billion | 13.29 Billion | 47.12 Billion | 11.29 Billion | 11.48 Billion |
| Gross Profit | 1.21 Billion | 1.2 Billion | 1.31 Billion | 4.82 Billion | 1.1 Billion | 1.19 Billion |
| Operating Expenses | 938.64 Million | 919.93 Million | 933.78 Million | 3.64 Billion | 910.39 Million | 928.7 Million |
| Selling, General and Administrative Expenses | 938.64 Million | 919 Million | 335 Million | - | 911 Million | 928 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.37 Million | -131 Thousand | -241 Thousand | 311 Thousand | 15 Thousand | 196 Thousand |
| Cost and Expenses | 12.94 Billion | 13.27 Billion | 14.22 Billion | 50.76 Billion | 12.2 Billion | 12.41 Billion |
| Operating Income | 273.63 Million | 289.68 Million | 385.08 Million | 1.18 Billion | 198.99 Million | 263.66 Million |
| Interest Expense | 35 Thousand | 44 Thousand | 53 Thousand | 282 Thousand | 62 Thousand | 70 Thousand |
| Income Tax Expense | 70.48 Million | 81.11 Million | 100.52 Million | 332.33 Million | 53.47 Million | 82.3 Million |
| Earnings before Tax | 275.17 Million | 273.36 Million | 389.32 Million | 1.18 Billion | 198.24 Million | 262.56 Million |
| Net Income | 204.69 Million | 192.24 Million | 288.8 Million | 850.7 Million | 144.76 Million | 180.26 Million |
| Earnings Per Share Basic | 21.24 | 19.97 | 30.12 | - | 15.12 | 19.13 |
| Earnings Per Share Diluted | 20.83 | 19.53 | 29.39 | - | 14.72 | 18.38 |
| Weighted Average Shares Outstanding | 9.63 Million | 9.62 Million | 9.83 Million | 9.5 Million | 9.78 Million | 9.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.82 Million | 9.84 Million | 9.82 Million | 9.77 Million | 9.83 Million | 9.85 Million |
| Gross Margin | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
| EBIT Margin | 0.03 | 0.03 | 0.04 | - | 0.03 | 0.03 |
| Profit Margin | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| EBITDA | 429.49 Million | 425.33 Million | 554.13 Million | - | 356.83 Million | 418.98 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
XGN
RKKE
600287
ODMUF
BIOX
7062